CervoMed CRVO Cash Flow Statement (2010-2026)

NASDAQ CRVO
$2.29 -0.02 (-0.87%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

CervoMed Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

CervoMed reported cash from operations of -$6.92M and free cash flow of -$6.92M for the quarter ended Jun 2026, down 6.2% year over year. This cash flow statement covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-12.20M-3.47M-4.53M-4.19M-0.88M-1.53M-0.53M-1.43M2.15M-2.36M-2.51M-2.32M-4.75M-6.71M-4.89M-6.26M-7.73M-8.09M-7.96M-6.57M
Depreciation and DepletionDep. & Depletion
0.02M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.02M
Share-based CompensationStock Comp.
0.16M0.25M0.28M0.28M0.08M0.08M0.07M0.06M0.11M0.16M0.22M0.58M0.27M0.34M0.36M0.50M0.29M0.30M0.35M0.36M
Deferred Taxes
-0.44M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
0.05M0.04M-0.17M0.05M-0.03M0.03M0.02M-0.03M-0.02M-0.01M314.00
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
8.64M-0.01M-0.03M-1.72M4.16M-0.86M0.21M-4.78M-0.34M-0.48M-0.38M-0.25M
Change in Working Capital
Change in ReceivablesChange Receivables
0.92M-0.92M0.26M1.99M-0.63M0.73M-1.00M-0.93M-0.43M
Change in Account PayablesChange Payables
0.24M0.24M-0.10M0.18M-0.23M0.29M0.36M0.43M0.35M-0.08M-0.43M0.09M0.77M-1.53M
Change in Accured ExpensesChange Accured Exp.
0.68M0.25M0.03M-0.44M0.47M0.16M0.36M-0.34M0.67M0.59M-0.27M-0.34M1.09M0.20M-0.29M0.71M0.45M-0.05M-1.10M-0.12M
Change in Other Operating AssetsOther Assets Change
-0.17M0.13M0.50M-0.38M-0.23M0.03M1.27M1.38M-1.10M-0.35M0.12M0.91M-0.33M-0.06M-0.20M0.42M-0.17M-0.38M0.43M-0.96M
Change in Other Operating LiabilitiesOther Liabilities Change
0.50M0.67M-0.62M0.57M0.83M-1.40M
Other Working Capital ChangesOther WC Changes
0.17M-0.13M-0.50M0.38M0.23M-0.03M-0.77M-0.72M0.48M0.35M0.46M-0.08M-1.07M0.06M0.20M-0.42M0.17M0.38M-0.43M0.96M
Cash from OperationsCash from Ops.
-2.97M-3.03M-4.73M-4.01M6.86M-0.69M-1.48M-1.96M-1.47M-2.54M-1.42M-2.20M-4.85M-8.05M-3.89M-6.51M-6.47M-6.58M-8.02M-6.92M
Investing Activities
Capital ExpendituresCapex
Change in Property, Plant and EquipmentChange in PP&E
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
22.72M8.90M6.37M40.57M3.90M3.63M7.10M9.75M3.92M4.63M0.99M2.47M
Sale and Maturity of InvestmentsInvestments Sold
9.00M9.75M7.00M9.50M3.00M-12.50M6.50M12.94M12.50M9.50M11.50M10.00M8.70M5.00M
Cash from Investing ActivitiesCash from Investing
0.00M-22.72M0.10M3.38M7.00M9.50M-9.50M-40.57M2.60M9.31M5.40M-0.25M7.58M5.37M7.71M2.53M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.81M-0.01M0.01M
Net Shares Issued and RepurchasedNet Shares Issued
0.81M-0.01M0.01M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
0.01M
Net Equity Issued and RepurchasedNet Equity Issued
0.01M0.81M-0.01M0.01M
Other financing activitiesOther financing
2.20M-0.09M
Cash from Financing ActivitiesCash from Financing
0.01M-0.01M11.24M-0.09M-0.01M4.59M0.01M18.91M
Additional items
Change in Cash
-2.97M-3.02M-27.44M-3.91M29.47M-0.69M-1.48M-1.96M9.77M-2.63M-1.42M3.64M-2.27M1.26M1.50M-2.18M1.12M-1.20M-0.29M14.52M
Ending Cash Balance
40.34M6.67M9.87M5.97M4.79M4.09M2.61M0.65M10.42M7.79M6.37M10.01M7.74M9.00M10.50M8.32M9.44M8.24M7.94M22.46M
Free Cash FlowFCF
-2.97M-3.03M-4.73M-4.01M6.86M-0.69M-1.48M-1.96M-1.47M-2.54M-1.42M-2.20M-4.85M-8.05M-3.89M-6.51M-6.47M-6.58M-8.02M-6.92M
Net Cash FlowNCF
-2.97M-3.02M-27.44M-3.91M10.23M6.31M8.02M-11.46M9.77M-2.63M-1.42M-42.77M-2.27M1.26M1.50M-2.18M1.12M-1.20M-0.29M14.52M
Interest Paid

CervoMed Cash Flow Statement API

Pull CervoMed's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRVO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY